Tower Research Capital (TRC)’s Arteris AIP Stock Holding History
Bought
Maintained
Sold
Other funds holding AIP
NIM
VCM
SM
N
Tower Research Capital (TRC)'s AIP Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Arteris (AIP) stake by 320% in Q1 2026, buying an estimated $38K and bringing the position to 3,145 shares worth $51.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2714.
Tower Research Capital (TRC) first reported a position in AIP in Q4 2021 and has held it in 17 quarters since. The position peaked at $73K in Q1 2023. 152 funds tracked by Wall St. Rank hold AIP as of Q1 2026.
- Tower Research Capital (TRC) held 3,145 shares of Arteris worth $51.7K as of Q1 2026.
- Tower Research Capital (TRC) bought 2,396 Arteris shares in Q1 2026, an estimated $38K.
- Arteris made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2714 holding.
- Tower Research Capital (TRC) first reported a position in Arteris in Q4 2021 and has held it in 17 quarters since.
- Tower Research Capital (TRC)'s Arteris position peaked at $73K in Q1 2023.
- 152 funds tracked by Wall St. Rank held Arteris as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.